Question Answered step-by-step PLEASE COMPLETE THE MEDICATION TEMPLATE BELOW FOR EACH OF THE FOLLOWING MEDICATIONS. PLEASE NOTE THAT THE TURN IT IN SCORE MUST BE LESS THAN 20% FOR THE ASSIGNMENT TO BE GRADED. Drug Name and Classification Indications for use Contraindications for use Side Effects Nursing Considerations Anti LipidemicsAtorvastatinGlipizideNiacinCholestyramine AntihypertensivesCardiac Specific Beta Blocker- MetoprololNon Specific Beta Blocker- PropranololDihydropyridine Calcium Channel Blocker- AmlodipineNon Dihydropyridine Calcium Channel Blocker- DiltiazemAce Inhibitor- LisinoprilAngiotensin Receptor Blocker- Losartan PotassiumHydralazinePrazosinClonidine DiureticsFurosemideHydrochlorothiazideSpironolactone Myocardial Infarction TreatmentNitroglycerin SL tabTissue Plasminogen Antigen Heart Failure TreatmentCardiac Glycosides- Digoxin Antiplatelet DrugsCoumadinVitamin KHeparinProtamine Sulfate AntidysrhythmicAdenosineAmlodipine Health Science Science Nursing NUR 215 Share QuestionEmailCopy link Comments (0)
Question Answered step-by-step PLEASE COMPLETE THE MEDICATION TEMPLATE BELOW FOR EACH OF THE FOLLOWING MEDICATIONS. PLEASE NOTE THAT THE TURN IT IN SCORE MUST BE LESS THAN 20% FOR THE ASSIGNMENT TO BE GRADED. Drug Name and Classification Indications for use Contraindications for use Side Effects Nursing Considerations Anti LipidemicsAtorvastatinGlipizideNiacinCholestyramine AntihypertensivesCardiac Specific Beta Blocker- MetoprololNon Specific Beta Blocker- PropranololDihydropyridine Calcium Channel Blocker- AmlodipineNon Dihydropyridine Calcium Channel Blocker- DiltiazemAce Inhibitor- LisinoprilAngiotensin Receptor Blocker- Losartan PotassiumHydralazinePrazosinClonidine DiureticsFurosemideHydrochlorothiazideSpironolactone Myocardial Infarction TreatmentNitroglycerin SL tabTissue Plasminogen Antigen Heart Failure TreatmentCardiac Glycosides- Digoxin Antiplatelet DrugsCoumadinVitamin KHeparinProtamine Sulfate AntidysrhythmicAdenosineAmlodipine Health Science Science Nursing NUR 215 Share QuestionEmailCopy link Comments (0)


